Large-scale testing (Phase 3)Active Not RecruitingNCT03671148
What this trial is testing
A Study Comparing Risankizumab to Placebo in Participants With Active Psoriatic Arthritis Including Those Who Have a History of Inadequate Response or Intolerance to Biologic Therapy(Ies)
Who this might be right for
Psoriatic Arthritis (PsA)
AbbVie 444